Data Integrity in Pharmaceuticals
Abstract
In the pharmaceutical world, maintaining data integrity represents one of the most critical aspects of ensuring that medications reach patients safely and effectively. This concept goes far beyond simple record keeping it encompasses the entire journey of information from initial research through final product delivery, ensuring that every piece of data remains accurate, reliable, complete, and consistent throughout this process. The regulatory landscape has evolved significantly, with organizations like the FDA establishing comprehensive guidelines such as 21 CFR Part 11, alongside internationally recognized frameworks like ALCOA+ and ICH Q7. These standards emphasize that pharmaceutical data must be attributable, legible, contemporaneous, original, and accurate, while also being complete, consistent, enduring, and available whenever needed. The importance of data integrity extends well beyond regulatory compliance. When pharmaceutical companies maintain robust data practices, they build trust with patients, protect public health, and foster transparency across all operational levels. However, the path to achieving this ideal is fraught with challenges, including human errors, inadequate digital infrastructure, poor documentation practices, and increasingly sophisticated cybersecurity threats. To address these challenges, companies are implementing comprehensive risk-based approaches, investing in advanced digital technologies, and cultivating organizational cultures that prioritize quality and accountability. This paper explores the fundamental principles governing data integrity, examines regulatory requirements, identifies common pitfalls, and presents best practices for maintaining data integrity in pharmaceutical operations.
Keywords:
Data Integrity, ALCOA and ALCOA principles, Data Retention, Data Governance, Organizational Culture, Cyber Security
Downloads
Download data is not yet available.
References
1. Ahmad S, Kumar A, Hafeez A. Importance of data integrity & its regulation in pharmaceutical industry. Authorea Preprints. 2022 Sep 8;8(1):306-313.
2. Vignesh M, Ganesh GN. Current status, challenges and preventive strategies to overcome data integrity issues in the pharmaceutical industry. Int J Appl Pharm. 2020 Nov 7;12(6):19-23.
3. Ingale MH, Tayade MC, Patil YP, Salunkhe R. Data Integrity Violations in the Pharmaceutical Industry and Regulatory Measures. International Journal of Pharmaceutical Quality Assurance. 2023;14(2):416-420.
4. Kavasidis I, Lallas E, Leligkou HC, Oikonomidis G, Karydas D, Gerogiannis VC, Karageorgos A. Deep transformers for computing and predicting ALCOA+ data integrity compliance in the pharmaceutical industry. Applied Sciences. 2023 Jun 28;13(13):7616.
5. James R, Das S, Kumari A, Rekdal M, Kulyadi GP, Sathyanarayana MB. A recent regulatory update on consequences of data integrity issues and its management in pharmaceutical scenario. Indian Journal of Pharmaceutical Education and Research. 2021 Apr 1;55(2):S616-S622.
6. Gupta KR. Ensuring data integrity in the pharmaceutical sector. International Journal of Pharmaceutical Chemistry and Analysis. 2023 Dec 8;10(4):218–219.
7. Shelke A, Shinde A, Shinde S, Shinde K, Shinde S, Mankar SD. Data Integrity in Pharmaceutical Sciences. International Journal of Pharmaceutical Sciences. 2025 Apr 9;3(4):1142-1148.
8. Singh S, Punjabi N, Shah D. Importance of Data Integrity in Pharmaceutical Industry. EPRA. International Journal of Economics, Business and Management Studies (EBMS). 2023;10(2):100-6.
9. The role of data integrity in implementing QMS in pharmaceutical manufacturing [Internet]. Pharma GMP; 2025 [cited 2025 Nov 30]. Available from:
https://www.pharmagmp.in/the-role-of-data-integrity-in-implementing-qms-in-pharmaceutical-manufacturing/
10. Avchar C M. Ensuring Data Integrity in the Pharmaceutical Industry: Challenges and Best Practices. International Journal of Pharmaceutical Sciences. 2025 Mar 31; 3(3):3238-3250.
11. Jale S C, Tendulkar N V, Chavan S M, Biradar S V, Sonawane J K, Narkar I P, Barge A D, Jadhav. An Illustration of Data Integrity. International Journal of Research Publication and Reviews. 2023 May ;4(5):5620-5629.
12. Solanki D, Patel D, Meshram D. Data Integrity: A cornerstone for compliance signature. 2022 Apr 12;3(2): 594-602.
13. Rattan AK. Data integrity: history, issues, and remediation of issues. PDA Journal of Pharmaceutical Science and Technology. 2018 Mar 1;72(2):105-116.
14. Raviteja M N, Gupta N V. A review on electronic data management in pharmaceutical industry. Asian J Pharm Clin Res. 2013 Apr 1;6(2):38-42.
15. Rupani ZM. Clinical trial master file migration: A preordained step for a centralized electronic trial master file. Perspectives in Clinical Research. 2020 Oct 1;11(4):139-143.
16. Durá M, Sánchez-García A, Sáez C, Leal F, Chis AE, González-Vélez H, García-Gómez JM. Towards a computational approach for the assessment of compliance of ALCOA+ Principles in pharma industry. Studies in health technology and informatics. 2022 May 25;294:755-759.
17. Gokulakrishnan D, Venkataraman S. Ensuring data integrity: Best practices and strategies in pharmaceutical industry. Intelligent Pharmacy. 2024 Sep 26;3(4):296-303.
18. Ullagaddi P. Safeguarding data integrity in pharmaceutical manufacturing. Journal of Advances in Medical and Pharmaceutical Sciences. 2024 Aug 17;26(8):64-75.
19. World Health Organization [Internet]. Expert Committee on Specifications for Pharmaceutical Preparations. Geneva, Switzerland: WHO; 2025 [cited 2025 Nov 30]. Available from:
https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/norms-and-standards-for-pharmaceuticals/expert-committee-on-specifications-for-pharmaceutical-preparations
20. ChemXpert [Internet]. Exploration of data types in the pharmaceutical industry. ChemXpert Blog. [cited 2025 Nov 30]. Available from:
https://chemxpert.com/blog/exploration-of-data-types-in-the-pharmaceutical-industry
21. Oronsky B, Burbano E, Stirn M, Brechlin J, Abrouk N, Caroen S, Coyle A, Williams J, Cabrales P, Reid TR. Data Management 101 for drug developers: A peek behind the curtain. Clinical and Translational Science. 2023 Jun 20;16(9):1497-1509.
22. Pharmaceutical Journal [Internet]. How to understand and interpret clinical data. The Pharmaceutical Journal [cited 2025 Nov 30]. Available from: https://pharmaceutical-journal.com/article/ld/how-to-understand-and-interpret-clinical-data
23. Žagar J, Mihelič J. Big data collection in pharmaceutical manufacturing and its use for product quality predictions. Scientific data. 2022 Mar 23;9(1):1-11.
24. Handoo S, Arora V, Khera D, Nandi PK, Sahu SK. A comprehensive study on regulatory requirements for development and filing of generic drugs globally. International journal of pharmaceutical investigation. 2012 Jul;2(3):99-105.
25. Ahluwalia K, Abernathy MJ, Algorri M, Cauchon NS, Perico-Norred NM, Youssef RY. The future of regulatory filings: digitalization. AAPS Open. 2025 Apr 18;11(1):1-12.
26. Charoo NA, Khan MA, Rahman Z. Data integrity issues in pharmaceutical industry: Common observations, challenges and mitigations strategies. International journal of pharmaceutics. 2023 Jan 25;631:122503.
27. Jain SK. Strategy to avoid data integrity issues in pharmaceutical industry. The Pharma Innovation. 2017 Feb 1;6(2, Part B):110.
28. World Health Organization. Annex 4: TRS 1033 [Internet]. Geneva, Switzerland: WHO; 2025 [cited 2025 Nov 30]. Available from:
https://www.who.int/publications/m/item/annex-4-trs-1033
29. Ajiga D, Okeleke PA, Folorunsho SO, Ezeigweneme C. Designing cybersecurity measures for enterprise software applications to protect data integrity. Computer Science & IT Research Journal. 2024 Aug 23;5(8):1920-1941.
30. Kantilal P D, Patil N A, Dhankani M, Pawar P S. Data Integrity Best Practices in Pharmaceutical Quality Assurance: A Thorough Review. Research & Reviews: A Journal of Pharmaceutical Science. 2024 Mar 30;15(1):22-30.
31. Boakai J. European Pharmaceutical Review [Internet]. Data integrity considerations in pharma and life sciences. European Pharmaceutical Review; 2024 Mar 12. [cited 2025 Nov 30]. Available from:
https://www.europeanpharmaceuticalreview.com/article/219686/data-integrity-considerations-in-pharma-and-life-sciences/
32. Ige AB, Chukwurah N, Idemudia C, Adebayo VI. Managing data lifecycle effectively: Best practices for data retention and archival processes. International Journal of Engineering Research and Development. 2024 Jul 31;20(8):199-207.
33. Duggineni S. Data integrity and risk. Open Journal of Optimization. 2023 Jun 6;12(2):25-33.
34. Faunce TA. Global Clinical Trials: Effective Implementation and Management. JAMA. 2012 May 16;307(19):2105.
35. Svärd P. Enterprise Content Management and the Records Continuum Model as strategies for long-term preservation of digital information. Records Management Journal. 2013 Nov 25;23(3):159-176.
36. Saxena A. Audit Trail in Pharma: A Review. Asian Journal of Pharmaceutical Research. 2022;12(4):359-363.
37. Qualityze [Internet]. Internal quality audit pharmaceutical industry. Qualityze.com. 2025 [cited 2025 Nov 30]. Available from:
https://www.qualityze.com/blogs/internal-quality-audit-pharmaceutical-industry
38. JAF Consulting. Good documentation practices for beginners: a step-by-step introduction [Internet]. JAF Consulting; 2025 [cited 2025 Nov 30]. Available from:
https://jafconsulting.com/good-documentation-practices-for-beginners-a-step-by-step-introduction/
39. Knors Pharma. Regulatory inspections in pharmaceutical industry [Internet]. Knors Pharma Blog; 2025 Aug 21 [cited 2025 Nov 30]. Available from:
https://www.knorspharma.com/blog/regulatory-inspections-in-pharmaceutical-industry/
40. IDBS. Data integrity in pharma industry [Internet]. IDBS Knowledge Base; 2024 Oct 21 [cited 2025 Nov 30]. Available from:
https://www.idbs.com/knowledge-base/data-integrity-in-pharma-industry/
41. Adhao V, Ambhore J, Chaudhari S. Transforming pharmaceutical quality assurance and validation through artificial intelligence. Artificial Intelligence in Health. 2025 Aug 13:025160032.
42. Sembiring M H, Novagusda F N. Enhancing Data Security Resilience in AI-Driven Digital Transformation: Exploring Industry Challenges and Solutions Through ALCOA+ Principles. Acta Informatica Medica. 2024;32(1):65-70.
43. GxP-CC. How automating processes can simplify pharma data integrity compliance [Internet]. GxP-CC Insights Blog; 2022 Aug 24 [cited 2025 Nov 30]. Available from:
https://www.gxp-cc.com/insights/blog/how-automating-processes-can-simplify-pharma-data-integrity-compliance/
44. Polu V S. Blockchain in Enterprise Resource Planning: Revolutionizing Supply Chain Transparency and Data Integrity.International Journal of Management Technology. 2025 Apr 16;12(1),48-57.
45. Lengston V. Blockchain for Public Health: Securing Data and Empowering Communities. European Journal of Medical and Health Research. 2025 May 1;3(3):4-10.
46. Sim C, Zhang H, Chang ML. Improving end-to-end traceability and pharma supply chain resilience using blockchain. Blockchain in Healthcare Today. 2022 Aug 12;5(31):1-10.
47. Padma A, Ramaiah M. Blockchain based solution for secure information sharing in pharma supply chain management. Heliyon. 2024 Nov 30;10(22): e40273.
48. Leal F, Chis A E, Caton S, González–Vélez H, García–Gómez J M, Durá M, Sánchez–García A, Sáez C, Karageorgos A, Gerogiannis V C, Xenakis A. Smart pharmaceutical manufacturing: Ensuring end-to-end traceability and data integrity in medicine production. Big Data Research. 2021 May 15;24:100172.
49. Pedro F, Veiga F, Mascarenhas-Melo F. Impact of GAMP 5, data integrity and QbD on quality assurance in the pharmaceutical industry: How obvious is it?. Drug Discovery Today. 2023 Nov 1;28(11):1-9.
50. Sridhar D. Leveraging blockchain technology for test data integrity in regulated industries. International journal. 2025 Feb 18;11(1):2927-2937.
51. Compliance Quest. Future trends in regulatory compliance for the pharmaceutical industry [Internet]. Compliance Quest: AI-powered PLM, QMS, EHS & SRM Platform. [cited 2025 Nov 30]. Available from:
https://www.compliancequest.com/cq-guide/regulatory-compliance-future-trends/
52. GMP Compliance. FDA warning letter on missing audit trails and raw data review [Internet]. GMP Compliance News; 2025 Feb 24 [cited 2025 Nov 30]. Available from:
https://www.gmp-compliance.org/gmp-news/fda-warning-letter-on-missing-audit-trails-and-raw-data-review
2. Vignesh M, Ganesh GN. Current status, challenges and preventive strategies to overcome data integrity issues in the pharmaceutical industry. Int J Appl Pharm. 2020 Nov 7;12(6):19-23.
3. Ingale MH, Tayade MC, Patil YP, Salunkhe R. Data Integrity Violations in the Pharmaceutical Industry and Regulatory Measures. International Journal of Pharmaceutical Quality Assurance. 2023;14(2):416-420.
4. Kavasidis I, Lallas E, Leligkou HC, Oikonomidis G, Karydas D, Gerogiannis VC, Karageorgos A. Deep transformers for computing and predicting ALCOA+ data integrity compliance in the pharmaceutical industry. Applied Sciences. 2023 Jun 28;13(13):7616.
5. James R, Das S, Kumari A, Rekdal M, Kulyadi GP, Sathyanarayana MB. A recent regulatory update on consequences of data integrity issues and its management in pharmaceutical scenario. Indian Journal of Pharmaceutical Education and Research. 2021 Apr 1;55(2):S616-S622.
6. Gupta KR. Ensuring data integrity in the pharmaceutical sector. International Journal of Pharmaceutical Chemistry and Analysis. 2023 Dec 8;10(4):218–219.
7. Shelke A, Shinde A, Shinde S, Shinde K, Shinde S, Mankar SD. Data Integrity in Pharmaceutical Sciences. International Journal of Pharmaceutical Sciences. 2025 Apr 9;3(4):1142-1148.
8. Singh S, Punjabi N, Shah D. Importance of Data Integrity in Pharmaceutical Industry. EPRA. International Journal of Economics, Business and Management Studies (EBMS). 2023;10(2):100-6.
9. The role of data integrity in implementing QMS in pharmaceutical manufacturing [Internet]. Pharma GMP; 2025 [cited 2025 Nov 30]. Available from:
https://www.pharmagmp.in/the-role-of-data-integrity-in-implementing-qms-in-pharmaceutical-manufacturing/
10. Avchar C M. Ensuring Data Integrity in the Pharmaceutical Industry: Challenges and Best Practices. International Journal of Pharmaceutical Sciences. 2025 Mar 31; 3(3):3238-3250.
11. Jale S C, Tendulkar N V, Chavan S M, Biradar S V, Sonawane J K, Narkar I P, Barge A D, Jadhav. An Illustration of Data Integrity. International Journal of Research Publication and Reviews. 2023 May ;4(5):5620-5629.
12. Solanki D, Patel D, Meshram D. Data Integrity: A cornerstone for compliance signature. 2022 Apr 12;3(2): 594-602.
13. Rattan AK. Data integrity: history, issues, and remediation of issues. PDA Journal of Pharmaceutical Science and Technology. 2018 Mar 1;72(2):105-116.
14. Raviteja M N, Gupta N V. A review on electronic data management in pharmaceutical industry. Asian J Pharm Clin Res. 2013 Apr 1;6(2):38-42.
15. Rupani ZM. Clinical trial master file migration: A preordained step for a centralized electronic trial master file. Perspectives in Clinical Research. 2020 Oct 1;11(4):139-143.
16. Durá M, Sánchez-García A, Sáez C, Leal F, Chis AE, González-Vélez H, García-Gómez JM. Towards a computational approach for the assessment of compliance of ALCOA+ Principles in pharma industry. Studies in health technology and informatics. 2022 May 25;294:755-759.
17. Gokulakrishnan D, Venkataraman S. Ensuring data integrity: Best practices and strategies in pharmaceutical industry. Intelligent Pharmacy. 2024 Sep 26;3(4):296-303.
18. Ullagaddi P. Safeguarding data integrity in pharmaceutical manufacturing. Journal of Advances in Medical and Pharmaceutical Sciences. 2024 Aug 17;26(8):64-75.
19. World Health Organization [Internet]. Expert Committee on Specifications for Pharmaceutical Preparations. Geneva, Switzerland: WHO; 2025 [cited 2025 Nov 30]. Available from:
https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/norms-and-standards-for-pharmaceuticals/expert-committee-on-specifications-for-pharmaceutical-preparations
20. ChemXpert [Internet]. Exploration of data types in the pharmaceutical industry. ChemXpert Blog. [cited 2025 Nov 30]. Available from:
https://chemxpert.com/blog/exploration-of-data-types-in-the-pharmaceutical-industry
21. Oronsky B, Burbano E, Stirn M, Brechlin J, Abrouk N, Caroen S, Coyle A, Williams J, Cabrales P, Reid TR. Data Management 101 for drug developers: A peek behind the curtain. Clinical and Translational Science. 2023 Jun 20;16(9):1497-1509.
22. Pharmaceutical Journal [Internet]. How to understand and interpret clinical data. The Pharmaceutical Journal [cited 2025 Nov 30]. Available from: https://pharmaceutical-journal.com/article/ld/how-to-understand-and-interpret-clinical-data
23. Žagar J, Mihelič J. Big data collection in pharmaceutical manufacturing and its use for product quality predictions. Scientific data. 2022 Mar 23;9(1):1-11.
24. Handoo S, Arora V, Khera D, Nandi PK, Sahu SK. A comprehensive study on regulatory requirements for development and filing of generic drugs globally. International journal of pharmaceutical investigation. 2012 Jul;2(3):99-105.
25. Ahluwalia K, Abernathy MJ, Algorri M, Cauchon NS, Perico-Norred NM, Youssef RY. The future of regulatory filings: digitalization. AAPS Open. 2025 Apr 18;11(1):1-12.
26. Charoo NA, Khan MA, Rahman Z. Data integrity issues in pharmaceutical industry: Common observations, challenges and mitigations strategies. International journal of pharmaceutics. 2023 Jan 25;631:122503.
27. Jain SK. Strategy to avoid data integrity issues in pharmaceutical industry. The Pharma Innovation. 2017 Feb 1;6(2, Part B):110.
28. World Health Organization. Annex 4: TRS 1033 [Internet]. Geneva, Switzerland: WHO; 2025 [cited 2025 Nov 30]. Available from:
https://www.who.int/publications/m/item/annex-4-trs-1033
29. Ajiga D, Okeleke PA, Folorunsho SO, Ezeigweneme C. Designing cybersecurity measures for enterprise software applications to protect data integrity. Computer Science & IT Research Journal. 2024 Aug 23;5(8):1920-1941.
30. Kantilal P D, Patil N A, Dhankani M, Pawar P S. Data Integrity Best Practices in Pharmaceutical Quality Assurance: A Thorough Review. Research & Reviews: A Journal of Pharmaceutical Science. 2024 Mar 30;15(1):22-30.
31. Boakai J. European Pharmaceutical Review [Internet]. Data integrity considerations in pharma and life sciences. European Pharmaceutical Review; 2024 Mar 12. [cited 2025 Nov 30]. Available from:
https://www.europeanpharmaceuticalreview.com/article/219686/data-integrity-considerations-in-pharma-and-life-sciences/
32. Ige AB, Chukwurah N, Idemudia C, Adebayo VI. Managing data lifecycle effectively: Best practices for data retention and archival processes. International Journal of Engineering Research and Development. 2024 Jul 31;20(8):199-207.
33. Duggineni S. Data integrity and risk. Open Journal of Optimization. 2023 Jun 6;12(2):25-33.
34. Faunce TA. Global Clinical Trials: Effective Implementation and Management. JAMA. 2012 May 16;307(19):2105.
35. Svärd P. Enterprise Content Management and the Records Continuum Model as strategies for long-term preservation of digital information. Records Management Journal. 2013 Nov 25;23(3):159-176.
36. Saxena A. Audit Trail in Pharma: A Review. Asian Journal of Pharmaceutical Research. 2022;12(4):359-363.
37. Qualityze [Internet]. Internal quality audit pharmaceutical industry. Qualityze.com. 2025 [cited 2025 Nov 30]. Available from:
https://www.qualityze.com/blogs/internal-quality-audit-pharmaceutical-industry
38. JAF Consulting. Good documentation practices for beginners: a step-by-step introduction [Internet]. JAF Consulting; 2025 [cited 2025 Nov 30]. Available from:
https://jafconsulting.com/good-documentation-practices-for-beginners-a-step-by-step-introduction/
39. Knors Pharma. Regulatory inspections in pharmaceutical industry [Internet]. Knors Pharma Blog; 2025 Aug 21 [cited 2025 Nov 30]. Available from:
https://www.knorspharma.com/blog/regulatory-inspections-in-pharmaceutical-industry/
40. IDBS. Data integrity in pharma industry [Internet]. IDBS Knowledge Base; 2024 Oct 21 [cited 2025 Nov 30]. Available from:
https://www.idbs.com/knowledge-base/data-integrity-in-pharma-industry/
41. Adhao V, Ambhore J, Chaudhari S. Transforming pharmaceutical quality assurance and validation through artificial intelligence. Artificial Intelligence in Health. 2025 Aug 13:025160032.
42. Sembiring M H, Novagusda F N. Enhancing Data Security Resilience in AI-Driven Digital Transformation: Exploring Industry Challenges and Solutions Through ALCOA+ Principles. Acta Informatica Medica. 2024;32(1):65-70.
43. GxP-CC. How automating processes can simplify pharma data integrity compliance [Internet]. GxP-CC Insights Blog; 2022 Aug 24 [cited 2025 Nov 30]. Available from:
https://www.gxp-cc.com/insights/blog/how-automating-processes-can-simplify-pharma-data-integrity-compliance/
44. Polu V S. Blockchain in Enterprise Resource Planning: Revolutionizing Supply Chain Transparency and Data Integrity.International Journal of Management Technology. 2025 Apr 16;12(1),48-57.
45. Lengston V. Blockchain for Public Health: Securing Data and Empowering Communities. European Journal of Medical and Health Research. 2025 May 1;3(3):4-10.
46. Sim C, Zhang H, Chang ML. Improving end-to-end traceability and pharma supply chain resilience using blockchain. Blockchain in Healthcare Today. 2022 Aug 12;5(31):1-10.
47. Padma A, Ramaiah M. Blockchain based solution for secure information sharing in pharma supply chain management. Heliyon. 2024 Nov 30;10(22): e40273.
48. Leal F, Chis A E, Caton S, González–Vélez H, García–Gómez J M, Durá M, Sánchez–García A, Sáez C, Karageorgos A, Gerogiannis V C, Xenakis A. Smart pharmaceutical manufacturing: Ensuring end-to-end traceability and data integrity in medicine production. Big Data Research. 2021 May 15;24:100172.
49. Pedro F, Veiga F, Mascarenhas-Melo F. Impact of GAMP 5, data integrity and QbD on quality assurance in the pharmaceutical industry: How obvious is it?. Drug Discovery Today. 2023 Nov 1;28(11):1-9.
50. Sridhar D. Leveraging blockchain technology for test data integrity in regulated industries. International journal. 2025 Feb 18;11(1):2927-2937.
51. Compliance Quest. Future trends in regulatory compliance for the pharmaceutical industry [Internet]. Compliance Quest: AI-powered PLM, QMS, EHS & SRM Platform. [cited 2025 Nov 30]. Available from:
https://www.compliancequest.com/cq-guide/regulatory-compliance-future-trends/
52. GMP Compliance. FDA warning letter on missing audit trails and raw data review [Internet]. GMP Compliance News; 2025 Feb 24 [cited 2025 Nov 30]. Available from:
https://www.gmp-compliance.org/gmp-news/fda-warning-letter-on-missing-audit-trails-and-raw-data-review
Statistics
96 Views | 180 Downloads
How to Cite
1.
Madhanraj S, A AS. Data Integrity in Pharmaceuticals. Int J Drug Reg Affairs [Internet]. 2025Dec.15 [cited 2026Jan.31];13(4):26-. Available from: https://www.ijdra.com/index.php/journal/article/view/816
Section
Review
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
